Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Gel4Med, Inc. in August, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI155199-01 | Phase I | 300,000 | August 14, 2020 | |||||||
A SBIR Phase I contract was awarded to Gel4Med, Inc. in July, 2020 for $380,007.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43EY031615-01 | Phase I | 380,007 | July 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Gel4Med, Inc. in April, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI143079-01A1 | Phase I | 300,000 | April 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Gel4Med, Inc. in April, 2020 for $1,699,924.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44GM133305-02 | Phase II | 1,699,924 | April 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Gel4Med, Inc. in April, 2019 for $348,852.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM133305-01 | Phase I | 348,852 | April 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Gel4Med, Inc. in April, 2017 for $223,866.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM122226-01 | Phase I | 223,866 | April 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Gel4Med, Inc. in May, 2016 for $223,369.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM117858-01 | Phase I | 223,369 | May 15, 2016 | |||||||
A SBIR Phase I contract was awarded to Gel4Med, Inc. in September, 2017 for $292,475.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM121127-01A1 | Phase I | 292,475 | September 22, 2017 | |||||||
A SBIR Phase I contract was awarded to Gel4Med, Inc. in September, 2017 for $298,530.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK115347-01 | Phase I | 298,530 | September 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Gel4Med, Inc. in February, 2019 for $225,000.0 USD from the National Science Foundation. | SBIR | 1843682 | Phase I | 225,000 | February 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Gel4Med, Inc. in October, 2023 for $1,119,996.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK137730-01 | Phase II | 1,119,996 | October 1, 2023 | |||||||
A SBIR Phase II contract was awarded to Gel4Med, Inc. in September, 2023 for $1,200,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2SB1GM133305-04A1 | Phase II | 1,200,000 | September 15, 2023 |